| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_331524805723a5a4cada42ce5fc156e3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-726 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57492
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5005 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 |
| filingDate |
2008-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2016-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24d1738b967eafb7e0ad64b106e902b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae174f15970c55e266d2a675ba9a4927
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d18d11883eae61a5bc8fd122a3e427bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9126a790555bbc3af7abdd79f0145dc6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_641702e428d0856cef14f0784704e3d2 |
| publicationDate |
2016-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2588507-T3 |
| titleOfInvention |
CCR4 as a therapeutic target for cancer |
| abstract |
An agent that inhibits the expression or activity of CCR4 for use in the treatment of a cancer patient having a solid tumor or a non-hematological tumor, said tumor comprising epithelial tumor cells expressing CCR4 in which the agent that inhibits the expression or CCR4 activity is: (i) an antibody that binds with CCR4; (ii) an antibody that binds CCR4 ligands CCL17 or CCL22; or (iii) a CCR4 antagonist. |
| priorityDate |
2007-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |